Literature DB >> 2788297

Effect of prostaglandin F3 alpha on gastric mucosal injury by ethanol in rats: comparison with prostaglandin F2 alpha.

T W Faust1, E Lee, J S Redfern, M Feldman.   

Abstract

In humans eicosapentaenoic acid can be converted to 3-series prostaglandins (PGF3 alpha, PGI3, and PGE3). Whether 3-series prostaglandins can protect the gastric mucosa from injury as effectively as their 2-series analogs is unknown. Therefore, we compared the protective effects of PGF3 alpha and PGF2 alpha against gross and microscopic gastric mucosal injury in rats. Animals received a subcutaneous injection of either PGF3 alpha or PGF2 alpha in doses ranging from 0 (vehicle) to 16.8 mumol/kg and 30 min later they received intragastric administration of 1 ml of absolute ethanol. Whether mucosal injury was assessed 60 min or 5 min after ethanol, PGF3 alpha was significantly less protective against ethanol-induced damage than PGF2 alpha. These findings indicate that the presence of a third double bond in the prostaglandin F molecule between carbons 17 and 18 markedly reduces the protective effects of this prostaglandin on the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788297     DOI: 10.1016/0090-6980(89)90098-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

Review 1.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

2.  Nonessential role of leukotrienes as mediators of acute gastric mucosal injury induced by aspirin in rats.

Authors:  M Lee; M Feldman
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

3.  Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach.

Authors:  J L Wallace; G W McKnight
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.